KR19990035972A - 극소량 투여 약물의 고체 투여 제형의 제조 방법 - Google Patents

극소량 투여 약물의 고체 투여 제형의 제조 방법 Download PDF

Info

Publication number
KR19990035972A
KR19990035972A KR1019980700633A KR19980700633A KR19990035972A KR 19990035972 A KR19990035972 A KR 19990035972A KR 1019980700633 A KR1019980700633 A KR 1019980700633A KR 19980700633 A KR19980700633 A KR 19980700633A KR 19990035972 A KR19990035972 A KR 19990035972A
Authority
KR
South Korea
Prior art keywords
drug
composition according
carrier
composition
pharmaceutical composition
Prior art date
Application number
KR1019980700633A
Other languages
English (en)
Korean (ko)
Inventor
제임스 알버트 네이퍼
닐 모어티머
캐런 트리오나 오브라이언
술탄 제임스 마넥
라진더 쿠마
마이클 시드니 죠오지 클라크
쥴리아 마리 루돈
Original Assignee
피터 존 기딩스
스미스클라인비이참피이엘시이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by 피터 존 기딩스, 스미스클라인비이참피이엘시이 filed Critical 피터 존 기딩스
Publication of KR19990035972A publication Critical patent/KR19990035972A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019980700633A 1995-07-29 1996-07-29 극소량 투여 약물의 고체 투여 제형의 제조 방법 KR19990035972A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GB9515624.6 1995-07-29
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process
GB9606684.0 1996-03-29

Publications (1)

Publication Number Publication Date
KR19990035972A true KR19990035972A (ko) 1999-05-25

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980700633A KR19990035972A (ko) 1995-07-29 1996-07-29 극소량 투여 약물의 고체 투여 제형의 제조 방법

Country Status (25)

Country Link
EP (1) EP0841902A2 (ru)
JP (1) JPH11510493A (ru)
KR (1) KR19990035972A (ru)
CN (1) CN1196677A (ru)
AP (1) AP858A (ru)
AR (1) AR004178A1 (ru)
AU (1) AU716961B2 (ru)
BG (1) BG102266A (ru)
BR (1) BR9609804A (ru)
CA (1) CA2228048A1 (ru)
CZ (1) CZ24798A3 (ru)
DZ (1) DZ2077A1 (ru)
EA (2) EA000740B1 (ru)
HU (1) HUP9900521A3 (ru)
IL (1) IL122897A0 (ru)
MA (1) MA23953A1 (ru)
MX (1) MX9800809A (ru)
NO (1) NO980384L (ru)
NZ (1) NZ315632A (ru)
OA (1) OA10659A (ru)
PL (1) PL325242A1 (ru)
SK (1) SK11098A3 (ru)
TR (1) TR199800156T1 (ru)
UY (1) UY24297A1 (ru)
WO (1) WO1997004750A2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
CA2323177A1 (en) 1998-03-11 1999-09-16 Susan Marie Milosovich Composition
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
AU2742102A (en) 2000-12-14 2002-06-24 Ortho Mcneil Pharm Inc Steroid hormone products and methods for preparing them
US20070202179A1 (en) * 2004-04-09 2007-08-30 FAULKNER Patrick Low Dose Pharmaceutical Products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
ES2219636T3 (es) * 1989-04-13 2004-12-01 Beecham Group P.L.C. Nuevos compuestos.
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
NO980384D0 (no) 1998-01-28
JPH11510493A (ja) 1999-09-14
AP9801170A0 (en) 1998-01-31
SK11098A3 (en) 1998-07-08
BR9609804A (pt) 1999-07-06
HUP9900521A2 (hu) 1999-06-28
AR004178A1 (es) 1998-11-04
IL122897A0 (en) 1998-08-16
WO1997004750A3 (en) 1997-03-27
EA199800179A1 (ru) 1998-10-29
EP0841902A2 (en) 1998-05-20
EA000740B1 (ru) 2000-02-28
CA2228048A1 (en) 1997-02-13
BG102266A (en) 1998-10-30
NZ315632A (en) 1999-11-29
AP858A (en) 2000-07-12
EA199901055A1 (ru) 2000-06-26
MX9800809A (es) 1998-04-30
WO1997004750A2 (en) 1997-02-13
CN1196677A (zh) 1998-10-21
MA23953A1 (fr) 1997-04-01
AU716961B2 (en) 2000-03-09
TR199800156T1 (xx) 1998-04-21
NO980384L (no) 1998-03-26
OA10659A (en) 2002-09-18
AU6738496A (en) 1997-02-26
DZ2077A1 (fr) 2002-07-22
PL325242A1 (en) 1998-07-06
HUP9900521A3 (en) 2001-04-28
UY24297A1 (es) 1997-01-23
CZ24798A3 (cs) 1998-06-17

Similar Documents

Publication Publication Date Title
US20070202159A1 (en) Pharmaceutical composition comprising stabilized statin particles
RU2349306C2 (ru) Лекарственные средства, содержащие тригидрат гидрохлорида варденафила
AU1211992A (en) Low dose dry pharmaceutical preparations
NO942470L (no) Sammensetninger for vedvarende frigivning og en fremgangsmåte for fremstilling av farmasöytiske sammensetninger
KR20010013994A (ko) 안정화된 벤즈이미다졸계 화합물 함유 조성물
SK3932000A3 (en) Pharmaceutical preparation, manufacturing process and use thereof
KR920006909B1 (ko) 니트렌디핀을 함유하는 고상 약제의 제조 방법
CN100528232C (zh) 包含酸不稳定活性成分的混悬液形式的药物制剂
US20020150618A1 (en) Process for preparing solid dosage forms of very low-dose drugs
JPH0330573B2 (ru)
KR19990035972A (ko) 극소량 투여 약물의 고체 투여 제형의 제조 방법
MXPA98000809A (en) Procedure to prepare forms of solid doses of very low dose of farm
KR20170128319A (ko) 항산화제를 함유하는 고형 제제
CA2275626C (en) Homogeneous preformulations containing high concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations
AU751607B2 (en) Method of treatment of dementia
JP2000239185A (ja) 医薬組成物
US5306507A (en) Process and composition containing pamabrom and pyrilamine maleate
KR920008161B1 (ko) 오메프라졸 경구용 약제의 제조방법
KR100806541B1 (ko) 아세클로페낙을 함유하는 제어 방출성 제제
US20040208932A1 (en) Stabilized paroxetine hydrochloride formulation
CA2105913A1 (en) Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions
Ghannam et al. Devazipide (MK-329) adsorption on microcrystalline cellulose
RU2192878C1 (ru) Лекарственное средство, применяемое при функциональных нарушениях мочеиспускания
JPH08175997A (ja) マレイン酸イルソグラジン経口投与用製剤およびその製造法
WO2004091582A1 (en) Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application